C000213839 Fees and Costs — BlackRock LifePath Smart Beta 2065 Fund
Data updated: 2020-06-24
The net expense ratio is 0.55% (1.66% before fee waivers). This share class carries a maximum front-end sales load of 5.25%.
C000213839 Fees and Expenses
Annual operating expenses and sales charges of C000213839. Prospectus, as of February 29, 2020.
| Annual operating expenses | |
|---|---|
| Management fee | 0.00% |
| 12b-1 fee | 0.25% |
| Other expenses | 1.21% |
| Gross expense ratio | 1.66% |
| Fee waiver | −1.11% |
| Net expense ratio | 0.55% |
| Sales charges | |
|---|---|
| Max front load | 5.25% |
| Max deferred load | 0.00% |
| Redemption fee | — |
C000213839 Costs Over Time
On $10,000 invested in C000213839, assuming 5% a year before costs, total costs come to $999 over 5 years, cutting the return by 1.70% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $525 | $525 | $525 |
| Fund expenses (net expense ratio 0.55%) | $55 | $172 | $299 |
| Lost growth on money paid in costs | $26 | $91 | $175 |
| Total costs | $606 | $788 | $999 |
| Value after costs | $9,894 | $10,789 | $11,764 |
| Impact on return, per year | 6.06% | 2.44% | 1.70% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.